Dual mechanisms by which miR-125b represses IRF4 to induce myeloid and B-cell leukemias
Alex Yick-Lun So1, Reeshelle Sookram1, Aadel A Chaudhuri2
1Department of Biology, California Institute of Technology, Pasadena, CA;
Abstract:
The oncomir microRNA-125b (miR-125b) is upregulated in a variety of human neoplastic blood disorders and constitutive upregulation of miR-125b in mice can promote myeloid and B-cell leukemia. We found that miR-125b promotes myeloid and B-cell neoplasm by inducing tumorigenesis in hematopoietic progenitor cells. Our study demonstrates that miR-125b induces myeloid leukemia by enhancing myeloid progenitor output from stem cells as well as inducing immortality, self-renewal, and tumorigenesis in myeloid progenitors. Through functional and genetic analyses, we demonstrated that miR-125b induces myeloid and B-cell leukemia by inhibiting interferon regulatory factor 4 (IRF4) but through distinct mechanisms; it induces myeloid leukemia through repressing IRF4 at the messenger RNA (mRNA) level without altering the genomic DNA and induces B-cell leukemia via genetic deletion of the gene encoding IRF4.
Insights
MicroRNA-125b (miR-125b) drives myeloid and B-cell leukemia by promoting cancer in blood stem cells. It inhibits IRF4 through different mechanisms, leading to distinct leukemias.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- MicroRNA-125b (miR-125b) is an oncomir implicated in various human blood cancers.
- Constitutive miR-125b upregulation in mice can lead to myeloid and B-cell leukemia.
Purpose of the Study:
- To investigate the role of miR-125b in inducing tumorigenesis in hematopoietic progenitor cells.
- To elucidate the distinct mechanisms by which miR-125b drives myeloid and B-cell leukemia.
Main Methods:
- Functional and genetic analyses were employed.
- Investigated miR-125b's impact on hematopoietic progenitor cells and stem cells.
Main Results:
- miR-125b promotes myeloid and B-cell neoplasm by inducing tumorigenesis in hematopoietic progenitor cells.
- miR-125b enhances myeloid progenitor output, immortality, self-renewal, and tumorigenesis.
- miR-125b inhibits interferon regulatory factor 4 (IRF4) through distinct mechanisms for myeloid and B-cell leukemia.
Conclusions:
- miR-125b induces myeloid leukemia by repressing IRF4 mRNA.
- miR-125b induces B-cell leukemia via genetic deletion of the IRF4 gene.
- miR-125b plays a critical role in the development of myeloid and B-cell leukemias through IRF4 inhibition.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Master Transcription Regulators
Experimental RNAi
Regulation of the Unfolded Protein Response


